Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F1FRV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,840
Award facts
- Contract value 100% obligated
- $15,839.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,839.60 by the Defense Logistics Agency on November 18, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 19, 2025, and performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement that extends through December 2026 and enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs.
This delivery order exemplifies the ongoing federal procurement relationship between AmerisourceBergen and the Defense Logistics Agency's Medical Supply Chain, through which the contractor supplies a broad range of medications, vaccines, and specialized medical commodities to military and veteran healthcare systems. Cosentyx is a specialty biologic medication used to treat inflammatory and autoimmune conditions, reflecting the company's established portfolio of delivering complex pharmaceutical products through competitive federal contracting mechanisms. AmerisourceBergen's consistent success in securing awards across the DLA's medical supply chain underscores its critical role as a pharmaceutical distributor for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1FRV?
SPE2DR26F1FRV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F1FRV worth?
The government has obligated $15,840 on SPE2DR26F1FRV.
Is contract SPE2DR26F1FRV an order under another contract?
Yes. SPE2DR26F1FRV is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FRV competed?
The extent of competition for SPE2DR26F1FRV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award